Revance Therapeutics Statistics
Total Valuation
NSE:VARDMNPOLY has a market cap or net worth of INR 4.53 billion. The enterprise value is 8.26 billion.
Market Cap | 4.53B |
Enterprise Value | 8.26B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 458.89M |
Shares Outstanding | n/a |
Shares Change (YoY) | +34.24% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 93.16M |
Valuation Ratios
The trailing PE ratio is 30.35.
PE Ratio | 30.35 |
Forward PE | n/a |
PS Ratio | 1.59 |
PB Ratio | -1.99 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.75, with an EV/FCF ratio of -8.03.
EV / Earnings | 55.38 |
EV / Sales | 2.90 |
EV / EBITDA | 44.75 |
EV / EBIT | 87.13 |
EV / FCF | -8.03 |
Financial Position
The company has a current ratio of 0.58
Current Ratio | 0.58 |
Quick Ratio | 0.10 |
Debt / Equity | n/a |
Debt / EBITDA | 20.25 |
Debt / FCF | -3.63 |
Interest Coverage | 0.67 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 2.15% |
Return on Invested Capital (ROIC) | 6.04% |
Return on Capital Employed (ROCE) | 8.28% |
Revenue Per Employee | 2.93M |
Profits Per Employee | 153,224 |
Employee Count | 974 |
Asset Turnover | 1.03 |
Inventory Turnover | 7.77 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.61% in the last 52 weeks. The beta is 0.51, so NSE:VARDMNPOLY's price volatility has been lower than the market average.
Beta (5Y) | 0.51 |
52-Week Price Change | +10.61% |
50-Day Moving Average | 11.57 |
200-Day Moving Average | 11.47 |
Relative Strength Index (RSI) | 29.28 |
Average Volume (20 Days) | 351,783 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:VARDMNPOLY had revenue of INR 2.85 billion and earned 149.24 million in profits. Earnings per share was 0.45.
Revenue | 2.85B |
Gross Profit | 495.86M |
Operating Income | 94.85M |
Pretax Income | 149.24M |
Net Income | 149.24M |
EBITDA | 184.69M |
EBIT | 94.85M |
Earnings Per Share (EPS) | 0.45 |
Balance Sheet
The company has 3.82 million in cash and 3.74 billion in debt, giving a net cash position of -3.74 billion.
Cash & Cash Equivalents | 3.82M |
Total Debt | 3.74B |
Net Cash | -3.74B |
Net Cash Per Share | n/a |
Equity (Book Value) | -2.27B |
Book Value Per Share | -4.96 |
Working Capital | -681.81M |
Cash Flow
In the last 12 months, operating cash flow was -982.77 million and capital expenditures -47.12 million, giving a free cash flow of -1.03 billion.
Operating Cash Flow | -982.77M |
Capital Expenditures | -47.12M |
Free Cash Flow | -1.03B |
FCF Per Share | n/a |
Margins
Gross margin is 17.40%, with operating and profit margins of 3.33% and 5.24%.
Gross Margin | 17.40% |
Operating Margin | 3.33% |
Pretax Margin | 5.24% |
Profit Margin | 5.24% |
EBITDA Margin | 6.48% |
EBIT Margin | 3.33% |
FCF Margin | n/a |
Dividends & Yields
NSE:VARDMNPOLY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -34.24% |
Shareholder Yield | -34.24% |
Earnings Yield | 3.30% |
FCF Yield | -22.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 17, 2024. It was a forward split with a ratio of 10.
Last Split Date | May 17, 2024 |
Split Type | Forward |
Split Ratio | 10 |
Scores
NSE:VARDMNPOLY has an Altman Z-Score of -1.1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.1 |
Piotroski F-Score | 5 |